Cancer of unknown primary is difficult to treat due to high heterogeneity in treatment response depending on the original site. Here, the authors use DNA methylation data to develop a machine learning classifier to predict the tissue of origin from a single blood draw, allowing potential treatment changes to improve efficacy.
- Alicia-Marie Conway
- Simon P. Pearce
- Dominic G. Rothwell
